Evidence map›Paper›PMID 28864473›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

HVEM Imprints Memory Potential on Effector CD8 T Cells Required for Protective Mucosal Immunity.

Pritesh Desai, Georges Abboud, Jessica Stanfield, Paul G Thomas, Jianxun Song, Carl F Ware, Michael Croft, Shahram Salek-Ardakani

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Accelerator or Brake: Immune Regulators in Malaria.Frontiers in cellular and infection microbiology · 2020
    Review
  10. Structural Basis of CD160:HVEM Recognition.Structure (London, England : 1993) · 2019
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pritesh DesaiDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32603.
Georges AbboudDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32603.
Jessica StanfieldDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32603.
Paul G ThomasDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105.
Jianxun SongDepartment of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, PA 17033.ORCID 0000-0002-9734-6176
Carl F WareDivision of Immune Regulation, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.ORCID 0000-0002-5006-418X
Michael CroftLaboratory of Molecular Immunology, Infectious and Inflammatory Diseases Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.ORCID 0000-0002-6062-3635
Shahram Salek-ArdakaniDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32603; ssalek@ufl.edu.ORCID 0000-0002-2336-8452

Funding

HVEM-BTLA system in InflammationR01AI067890 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI WARE, CARL F · 2007 to 2016
$4.3M
TNFR Members in T Cell Immunity to VacciniaR01AI067341 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2006 to 2010
$2.3M
HVEM-BTLA Pathway in LymphomaR01CA164679 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI WARE, CARL F · 2012 to 2016
$2.0M
LIGHT_HVEM_BTLA axis in protective anti_viral immunityR01AI087734 · NIAID · UNIVERSITY OF FLORIDA · PI SALEK-ARDAKANI, SHAHRAM · 2011 to 2015
$1.6M
T Cell Memory to Respiratory Viral InfectionsR21AI077079 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SALEK-ARDAKANI, SHAHRAM · 2007 to 2008
$515k
TNFR Members in T Cell Immunity to VacciniaR56AI067341 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2012 to 2012
$348k
NCI NIH HHS R01 CA164679NIAID NIH HHS R01 AI067341NIAID NIH HHS R01 AI067890NIAID NIH HHS R01 AI087734NIAID NIH HHS R21 AI077079NIAID NIH HHS R56 AI067341
6 · The paper itself

Abstract

Mucosal immunity to reinfection with a highly virulent virus requires the accumulation and persistence of memory CD8 T cells at the site of primary infection. These cells may derive from memory precursor effector cells (MPECs), which are distinct from short-lived effector cells that provide acute protection but are often destined to die. Using respiratory virus infection, we show that herpes virus entry mediator (HVEM; TNFRSF14), a member of the TNF receptor superfamily, provides key signals for MPEC persistence. HVEM-deficient CD8 T cells expanded normally but were skewed away from MPECs with resultant poor development of circulating and lung-resident memory cells. HVEM was selectively expressed on MPECs whereas MPECs deficient in HVEM failed to survive in adoptive transfer recipients. As a consequence, HVEM-deficient recipients failed to afford protection against respiratory reinfection with influenza virus. HVEM therefore represents a critical signal for MPECs and development of protective mucosal CD8 T cell memory.

Indexed as

Adoptive TransferAnimalsCD8-Positive T-LymphocytesCells, CulturedCell Self RenewalDisease Models, AnimalFemaleImmunity, MucosalImmunologic MemoryInfluenza A virusMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicOrthomyxoviridae InfectionsPrecursor Cells, T-LymphoidReceptors, Tumor Necrosis Factor, Member 14Tnfrsf14 protein, mouse

Identifiers

PMID28864473
PMCPMC5783181

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.